Population impact of strategies for identifying groups at high risk of type 2 diabetes

Preventive Medicine

Volumn 42, Issue 5, 2006, Pages 364-368

  Harding, Anne Helen ^a   Griffin, Simon J ^b   Wareham, Nicholas J ^a  

^a MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cohort study; Primary prevention; Risk factor; Screening; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM;

ADULT; AGED; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENGLAND; EXERCISE; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 33646547881     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2006.01.013     Document Type: Article

References (21)

1. Barker D.J., Gardner M.J., and Power C. Incidence of diabetes amongst people aged 18-50 years in nine British towns: a collaborative study. Diabetologia 22 (1982) 421-425
2. Bennett P.H. Primary prevention of NIDDM: a practical reality. Diabetes Metab. Rev. 13 (1997) 105-111
3. Borch-Johnsen K., Lauritzen T., Glumer C., and Sandbaek A. Screening for Type 2 diabetes-should it be now?. Diabet. Med. 20 (2003) 175-181
4. Day N., Oakes S., Luben R., Khaw K.T., Bingham S., Welch A., and Wareham N. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br. J. Cancer 80 Suppl. 1 (1999) 95-103
5. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 (2002) 393-403
6. Griffin S.J., Little P.S., Hales C.N., Kinmonth A.L., and Wareham N.J. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab. Res. Rev. 16 (2000) 164-171
7. Helmrich S.P., Ragland D.R., Leung R.W., and Paffenbarger Jr. R.S. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 325 (1991) 147-152
8. Lindstrom J., and Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26 (2003) 725-731
9. Manson J.E., Nathan D.M., Krolewski A.S., Stampfer M.J., Willett W.C., and Hennekens C.H. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 268 (1992) 63-67
10. National Statistics Online Deaths by area of usual residence, numbers and standardised, 2002, http://www.statistics.gov.uk/STATBASE/Expodata/Spreadsheets/D6897.xls.
11. Park P.J., Griffin S.J., Sargeant L., and Wareham N.J. The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care 25 (2002) 984-988
12. Perry I.J., Wannamethee S.G., Walker M.K., Thomson A.G., Whincup P.H., and Shaper A.G. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. Br. Med. J. 310 (1995) 560-564
13. Pierce M., Harding D., Ridout D., Keen H., and Bradley C. Risk and prevention of type II diabetes: offspring's views. Br. J. Gen. Pract. 51 (2001) 194-199
14. Rao G. Diagnostic yield of screening for type 2 diabetes in high-risk patients: a systematic review. J. Fam. Pract. 48 (1999) 805-810
15. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br. Med. J. Clin. Res. Ed. 282 (1981) 1847-1851
16. Segal L., Dalton A., Richardson J., and Dalton A.C. Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus. Health Promot. Int. 13 (1998) 197-210
17. Stern M.P., Fatehi P., Williams K., and Haffner S.M. Predicting future cardiovascular disease: do we need the oral glucose tolerance test?. Diabetes Care 25 (2002) 1851-1856
18. Stern M.P., Williams K., and Haffner S.M. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?. Ann. Intern. Med. 136 (2002) 575-581
19. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., Keinanen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M., Salminen V., Uusitupa M., Aunola S., Cepaitis Z., Moltchanov V., Hakumaki M., Mannelin M., Martikkala V., and Sundvall J. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Eng. J. Med. 344 (2001) 1343-1350
20. Wareham N.J., and Griffin S.J. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. Br. Med. J. 322 (2001) 986-988
21. Wareham N.J., Jakes R.W., Rennie K.L., Schuit J., Mitchell J., Hennings S., and Day N.E. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 6 (2003) 407-413